Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, European Working Group on Sarcopenia in Older People, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23.

Article  PubMed  PubMed Central  Google Scholar 

Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019;22:10–22.

Article  PubMed  Google Scholar 

Simonsen C, de Heer P, Bjerre ED, Suetta C, Hojman P, Pedersen BK, et al. Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis. Ann Surg. 2018;268:58–69.

Article  PubMed  Google Scholar 

Shen Y, Hao Q, Zhou J, Dong B. The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis. BMC Geriatr. 2017;17:188.

Article  PubMed  PubMed Central  Google Scholar 

Yang Z, Zhou X, Ma B, Xing Y, Jiang X, Wang Z. Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review. J Gastrointest Surg. 2018;22:1890–902.

Article  PubMed  Google Scholar 

Rinninella E, Cintoni M, Raoul P, Pozzo C, Strippoli A, Bria E, et al. Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis. Clin Nutr. 2020;39:2045–54.

Article  PubMed  Google Scholar 

Watanabe J, Osaki T, Ueyama T, Koyama M, Iki M, Endo K, et al. The combination of preoperative skeletal muscle quantity and quality is an important indicator of survival in elderly patients undergoing curative gastrectomy for gastric cancer. World J Surg. 2021;45:2868–77.

Article  PubMed  Google Scholar 

Fang Z, Shang L, Li L. Impact of low skeletal muscle mass on complications and survival for gastric cancer: a propensity score matching analysis. Front Surg. 2022;9: 901142.

Article  PubMed  PubMed Central  Google Scholar 

Taniguchi Y, Kurokawa Y, Takahashi T, Saito T, Yamashita K, Tanaka K, et al. Impacts of preoperative psoas muscle mass and visceral fat area on postoperative short- and long-term outcomes in patients with gastric cancer. World J Surg. 2021;45:815–21.

Article  PubMed  Google Scholar 

Nakamura T, Hojo Y, Kumamoto T, Kurahashi Y, Ishida Y, Shinohara H. History of the lymph node numbering system in the Japanese Classification of Gastric Carcinoma since 1962. Surg Today. 2022;52:1515–23.

Article  PubMed  Google Scholar 

Matsui R, Inaki N, Tsuji T. Impact of visceral adipose tissue on long-term outcomes after gastrectomy for advanced gastric cancer. Nutrition. 2022;97: 111619.

Article  PubMed  Google Scholar 

Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.

Article  Google Scholar 

Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24:1–21.

Article  Google Scholar 

Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.

Article  PubMed  Google Scholar 

Huiskamp LFJ, Chargi N, Devriese LA, May AM, Huitema ADR, de Bree R. The predictive value of low skeletal muscle mass assessed on cross-sectional imaging for anti-cancer drug toxicity: a systematic review and meta-analysis. J Clin Med. 2020;9:3780.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Botsen D, Ordan MA, Barbe C, Mazza C, Perrier M, Moreau J, et al. Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients. BMC Cancer. 2018;18:955.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, ACTS-GC Group, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

Article  CAS  PubMed  Google Scholar 

Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387–93.

Article  CAS  PubMed  Google Scholar 

Kakeji Y, Yoshida K, Kodera Y, Kochi M, Sano T, Ichikawa W, et al. Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07. Gastric Cancer. 2022;25:188–96.

Article  CAS  PubMed  Google Scholar 

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.

Article  PubMed  Google Scholar 

Matsui R, Inaki N, Tsuji T. The impact of the preoperative hand grip strength on the long-term outcomes after gastrectomy for advanced gastric cancer. Surg Today. 2021;51:1179–87.

Article  PubMed  Google Scholar 

Lu H, Zhao B, Huang R, Sun Y, Zhu Z, Xu H, et al. Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy. BMC Gastroenterol. 2021;21:15.

Article  PubMed  PubMed Central  Google Scholar 

Li Z, Bai B, Xie F, Zhao Q. Distal versus total gastrectomy for middle and lower-third gastric cancer: a systematic review and meta-analysis. Int J Surg. 2018;53:163–70.

Article  PubMed  Google Scholar 

Jun L, Robinson M, Geetha T, Broderick TL, Babu JR. Prevalence and mechanisms of skeletal muscle atrophy in metabolic conditions. Int J Mol Sci. 2023;24:2973.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Belavý DL, Armbrecht G, Richardson CA, Felsenberg D, Hides JA. Muscle atrophy and changes in spinal morphology: is the lumbar spine vulnerable after prolonged bed-rest? Spine. 2011;36:137–45.

Article  PubMed  Google Scholar 

Lexell J, Taylor CC, Sjöström M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84:275–94.

Article  CAS  PubMed  Google Scholar 

Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med. 2004;34:809–24.

Article  PubMed  Google Scholar